In-utero exposure to tenofovir is associated with impaired fetal and infant growth: need for follow-up studies in combination antiretroviral therapy/HIV-exposed infants: author's reply

AIDS. 2017 Feb 20;31(4):596-598. doi: 10.1097/QAD.0000000000001364.
No abstract available

Publication types

  • Comment

MeSH terms

  • Anti-HIV Agents
  • Follow-Up Studies
  • HIV Infections*
  • Humans
  • Infant
  • Infectious Disease Transmission, Vertical
  • Pregnancy Complications, Infectious
  • Tenofovir*

Substances

  • Anti-HIV Agents
  • Tenofovir